Stockreport

Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF HOUSTON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagno [Read more]